Implementing an Electronic End-of-Life Chemotherapy Utilization Measure

J Oncol Pract. 2019 Apr;15(4):220-223. doi: 10.1200/JOP.18.00408. Epub 2019 Mar 18.

Authors

Affiliations

¹ 1 Flatiron Health, New York, NY.
² 2 Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.
³ 3 Huntsman Cancer Hospital, Salt Lake City, UT.
⁴ 4 The Center for Cancer and Blood Disorders, Fort Worth, TX.
⁵ 5 Yale University, New Haven, CT.
⁶ 6 Stanford University School of Medicine, Stanford, CA.
⁷ 7 Memorial Sloan Kettering Cancer Center, New York, NY.

PMID: 30883256
DOI: 10.1200/JOP.18.00408

No abstract available

Publication types

Editorial

MeSH terms

Antineoplastic Agents / therapeutic use*
Drug Utilization / statistics & numerical data
Drug Utilization Review / methods*
Electronic Health Records*
Humans
Neoplasms / drug therapy*
Prescription Drug Overuse / prevention & control
Prescription Drug Overuse / statistics & numerical data
Quality Improvement / organization & administration
Terminal Care / methods*
Terminal Care / standards

Substances

Antineoplastic Agents